iopidine 10 mg/ml øjendråber, opløsning
essential pharma limited - apraclonidinhydrochlorid - øjendråber, opløsning - 10 mg/ml
tomahawk 200 ec emulsionskoncentrat
adama northern europe b.v. - fluroxypyr - emulsionskoncentrat - 200 g/l fluroxypyr
cleave
adama - florasulam 2,5 g/l + fluroxypyr 100 g/l (10.7 % w/w) - herbicider
mixin
adama - florasulam 2,5 g/l + fluroxypyr 100 g/l (10.7 % w/w) - herbicider
cleave suspoemulsion
adama northern europe b.v. - florasulam, fluroxypyr - suspoemulsion - 2,5 g/l florasulam ; 100 g/l fluroxypyr
tomahawk 180 ec emulsionskoncentrat
adama northern europe b.v. - fluroxypyr - emulsionskoncentrat - 180 g/l fluroxypyr
xtandi
astellas pharma europe b.v. - enzalutamide - prostatiske neoplasmer - endokrine terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
granocyte 13,4 mill. ie pulver og solvens til injektions- /infusionsvæske, opløsning
sanofi a/s - lenograstim - pulver og solvens til injektions- /infusionsvæske, opløsning - 13,4 mill. ie
zoloft 20 mg/ml koncentrat til oral opløsning
pfizer aps - sertralinhydrochlorid - koncentrat til oral opløsning - 20 mg/ml